Quantitative mass spectrometry for bacterial protein toxins - A sensitive, specific, high-throughput tool for detection and diagnosis

Molecules

Volumn 16, Issue 3, 2011, Pages 2391-2413

  Boyer, Anne E ^a   Gallegos Candela, Maribel ^a   Lins, Renato C ^a   Kuklenyik, Zsuzsanna ^a   Woolfitt, Adrian ^a   Moura, Hercules ^a   Suzanne Kalb, ^a   Quinn, Conrad P ^a   Barr, John R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Anthrax edema factor; Anthrax lethal factor; Bacillus anthracis; Clostridium botulinum; Mass spectrometry; Neurotoxins

Indexed keywords

BACTERIAL PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BACILLUS ANTHRACIS; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; LIMIT OF DETECTION; METHODOLOGY; MOLECULAR GENETICS; SEQUENCE HOMOLOGY; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; BACILLUS ANTHRACIS; BACTERIAL PROTEINS; LIMIT OF DETECTION; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 79953071793     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16032391     Document Type: Article

References (51)

1. Rossetto, O.; de Bernard, M.; Pellizzari, R.; Vitale, G.; Caccin, P.; Schiavo, G.; Montecucco, C. Bacterial toxins with intracellular protease activity. Clin. Chim. Acta 2000, 291, 189-199. (Pubitemid 30089764)
2. Tournier, J.N.; Quesnel-Hellmann, A.; Cleret, A.; Vidal, D.R. Contribution of toxins to the pathogenesis of inhalational anthrax. Cell Microbiol. 2007, 9, 555-565. (Pubitemid 46231963)
3. Boyer, A.E.; Moura, H.; Woolfitt, A.R.; Kalb, S.R.; McWilliams, L.G.; Pavlopoulos, A.; Schmidt, J.G.; Ashley, D.L.; Barr, J.R. From the mouse to the mass spectrometer: Detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry. Anal. Chem. 2005, 77, 3916-3924. (Pubitemid 40934253)
4. Kalb, S.R.; Moura, H.; Boyer, A.E.; McWilliams, L.G.; Pirkle, J.L.; Barr, J.R. The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples. Anal. Biochem. 2006, 351, 84-92.
5. Kalb, S.R.; Lou, J.; Garcia-Rodriguez, C.; Geren, I.N.; Smith, T.J.; Moura, H.; Marks, J.D.; Smith, L.A.; Pirkle, J.L.; Barr, J.R. Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies. PLoS One 2009, 4, e5355.
6. Boyer, A.E.; Quinn, C.P.; Hoffmaster, A.R.; Kozel, T.R.; Saile, E.; Marston, C.K.; Percival, A.; Plikaytis, B.D.; Woolfitt, A.R.; Gallegos, M.; Sabourin, P.; McWilliams, L.G.; Pirkle, J.L.; Barr, J.R. Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques. Infect. Immun. 2009, 77, 3432-3441.
7. Boyer, A.E.; Quinn, C.P.; Woolfitt, A.R.; Pirkle, J.L.; McWilliams, L.G.; Stamey, K.L.; Bagarozzi, D.A.; Hart, J.C., Jr.; Barr, J.R. Detection and quantification of anthrax lethal factor in serum by mass spectrometry. Anal. Chem. 2007, 79, 8463-8470. (Pubitemid 350171353)
8. Pellizzari, R.; Rossetto, O.; Schiavo, G.; Montecucco, C. Tetanus and botulinum neurotoxins: Mechanism of action and therapeutic uses. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1999, 354, 259-268. (Pubitemid 29365599)
9. Hill, K.K.; Smith, T.J.; Helma, C.H.; Ticknor, L.O.; Foley, B.T.; Svensson, R.T.; Brown, J.L.; Johnson, E.A.; Smith, L.A.; Okinaka, R.T.; Jackson, P.J.; Marks, J.D. Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J. Bacteriol. 2007, 189, 818-832. (Pubitemid 46183856)
10. Schiavo, G.; Matteoli, M.; Montecucco, C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 2000, 80, 717-766. (Pubitemid 30164948)
11. Moriishi, K.; Koura, M.; Abe, N.; Fujii, N.; Fujinaga, Y.; Inoue, K.; Ogumad, K. Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms. Biochim. Biophys. Acta 1996, 1307, 123-126.
12. Moura, H.T.R.; Woolfitt, A.R.; Gallegos-Candela, M.; McWilliams, L.G.; Solano, M.I.; Pirkle, J.L.; Barr, J.R. Studies on Botulinum Neurotoxins Type /C1 and mosaic /DC Using Endopep-MS and Proteomics. FEMS Immunol. Microbiol. 2011, in press.
13. Smith, T.J.; Lou, J.; Geren, I.N.; Forsyth, C.M.; Tsai, R.; Laporte, S.L.; Tepp, W.H.; Bradshaw, M.; Johnson, E.A.; Smith, L.A.; Marks, J.D. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect. Immun. 2005, 73, 5450-5457. (Pubitemid 41192979)
14. Mock, M.; Mignot, T. Anthrax toxins and the host: A story of intimacy. Cell Microbiol. 2003, 5, 15-23. (Pubitemid 36395117)
15. Turk, B.E. Manipulation of host signalling pathways by anthrax toxins. Biochem. J. 2007, 402, 405-417. (Pubitemid 46423878)
16. Klimpel, K.R.; Molloy, S.S.; Thomas, G.; Leppla, S.H. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc. Natl. Acad. Sci. USA 1992, 89, 10277-10281.
17. Molloy, S.S.; Bresnahan, P.A.; Leppla, S.H.; Klimpel, K.R.; Thomas, G. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J. Biol. Chem. 1992, 267, 16396-16402.
18. Kintzer, A.F.; Thoren, K.L.; Sterling, H.J.; Dong, K.C.; Feld, G.K.; Tang, II; Zhang, T.T.; Williams, E.R.; Berger, J.M.; Krantz, B.A. The protective antigen component of anthrax toxin forms functional octameric complexes. J. Mol. Biol. 2009, 392, 614-629.
19. Warfel, J.M.; Steele, A.D.; D'Agnillo, F. Anthrax lethal toxin induces endothelial barrier dysfunction. Am. J. Pathol. 2005, 166, 1871-1881. (Pubitemid 40734409)
20. Sweeney, D.A.; Cui, X.; Solomon, S.B.; Vitberg, D.A.; Migone, T.S.; Scher, D.; Danner, R.L.; Natanson, C.; Subramanian, G.M.; Eichacker, P.Q. Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines. J. Infect. Dis. 2010, 202, 1885-1896.
21. Boyer, A.E.; Quinn, C.P.; Hoffmaster, A.R.; Kozel, T.; Gallegos, M.; Saile, E.; Marston, C.; Beesley, C.; Percival, A.; Lins, R.; Woolfitt, A.; Pirkle, J.L.; Barr, J.R. Association of Early Lethal Factor Levels with Survival during Inhalation Anthrax in Rhesus Macaques. In Proceedings of ASM Biodefense and Emerging Diseases Research Meeting, Baltimore, MD, USA, 6-9 February 2010; American Society for Microbiology: Washington, DC, USA, 2010.
22. Walsh, J.J.; Pesik, N.; Quinn, C.P.; Urdaneta, V.; Dykewicz, C.A.; Boyer, A.E.; Guarner, J.; Wilkins, P.; Norville, K.J.; Barr, J.R.; Zaki, S.R.; Patel, J.B.; Reagan, S.P.; Pirkle, J.L.; Treadwell, T.A.; Messonnier, N.R.; Rotz, L.D.; Meyer, R.F.; Stephens, D.S. A case of naturally acquired inhalation anthrax: Clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Clin. Infect. Dis. 2007, 44, 968-971. (Pubitemid 46452063)
23. Ferreira, J.L.; Maslanka, S.; Johnson, E.; Goodnough, M. Detection of botulinal neurotoxins A, B, E, and F by amplified enzyme-linked immunosorbent assay: Collaborative study. J. AOAC Int. 2003, 86, 314-331.
24. Ezzell, J.W., Jr.; Abshire, T.G. Serum protease cleavage of Bacillus anthracis protective antigen. J. Gen. Microbiol. 1992, 138, 543-549.
25. Panchal, R.G.; Halverson, K.M.; Ribot, W.; Lane, D.; Kenny, T.; Abshire, T.G.; Ezzell, J.W.; Hoover, T.A.; Powell, B.; Little, S.; Kasianowicz, J.J.; Bavari, S. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity. J. Biol. Chem. 2005, 280, 10834-10839. (Pubitemid 40395947)
26. Barr, J.R.; Maggio, V.L.; Patterson, D.G., Jr.; Cooper, G.R.; Henderson, L.O.; Turner, W.E.; Smith, S.J.; Hannon, W.H.; Needham, L.L.; Sampson, E.J. Isotope dilution-mass spectrometric quantification of specific proteins: Model application with apolipoprotein A-I. Clin. Chem. 1996, 42, 1676-1682. (Pubitemid 26354748)
27. Williams, T.L.; Luna, L.; Guo, Z.; Cox, N.J.; Pirkle, J.L.; Donis, R.O.; Barr, J.R. Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. Vaccine 2008, 26, 2510-2520.
28. Kuklenyik, Z.; Boyer, A.E.; Lins, R.; Quinn, C.P.; Gallegos-Candela, M.; Woolfitt, A.R.; Pirkle, J.L.; Barr, J.R. Comparison of MALDI-TOF-MS and HPLC-ESI-MS/MS for Endopeptidase Activity Based Quantification of Anthrax Lethal Factor in Serum. Anal. Chem. 2011, in press.
29. Lins, R.C.; Boyer, A.E.; Kuklenyik, Z.; Quinn, C.P.; Gallegos-Candela, M.; Leysath, C.E.; Chen, Z.; Chen, K.; Makiya, M.; Leppla, S.H.; Pirkle, J.L.; Barr, J.R. In A High Sensitivity Adenylate Cyclase Assay for Anthrax Edema factor., Proceedings of 58th ASMS Conference on Mass Spectrometry and Allied Topics, Salt Lake City, UT, USA, 23-27 May 2010; American Society for Mass Spectrometry: Santa Fe, NM, USA, 2010.
30. Turk, B.E.; Wong, T.Y.; Schwarzenbacher, R.; Jarrell, E.T.; Leppla, S.H.; Collier, R.J.; Liddington, R.C.; Cantley, L.C. The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat. Struct. Mol. Biol. 2004, 11, 60-66. (Pubitemid 38173442)
31. Pellizzari, R.; Guidi-Rontani, C.; Vitale, G.; Mock, M.; Montecucco, C. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett. 1999, 462, 199-204.
32. Duesbery, N.S.; Webb, C.P.; Leppla, S.H.; Gordon, V.M.; Klimpel, K.R.; Copeland, T.D.; Ahn, N.G.; Oskarsson, M.K.; Fukasawa, K.; Paull, K.D.; Vande Woude, G.F. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 1998, 280, 734-737. (Pubitemid 28243347)
33. Vitale, G.; Bernardi, L.; Napolitani, G.; Mock, M.; Montecucco, C. Susceptibility of mitogenactivated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem. J. 2000, 352 (Pt. 3), 739-745. (Pubitemid 32015030)
34. Guo, Q.; Shen, Y.; Zhukovskaya, N.L.; Florian, J.; Tang, W.J. Structural and kinetic analyses of the interaction of anthrax adenylyl cyclase toxin with reaction products cAMP and pyrophosphate. J. Biol. Chem. 2004, 279, 29427-29435. (Pubitemid 38915822)
35. Voth, D.E.; Ballard, J.D. Clostridium difficile toxins: Mechanism of action and role in disease. Clin. Microbiol. Rev. 2005, 18, 247-263. (Pubitemid 40548293)
36. Jank, T.; Giesemann, T.; Aktories, K. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 2007, 17, 15R-22R. (Pubitemid 46432006)
37. Leppla, S.H. Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. USA 1982, 79, 3162-3166. (Pubitemid 12008374)
38. Gallegos-Candela, M.; Boyer, A.E.; Quinn, C.P.; Woolfitt, A.R.; Barr, J.R. Validation of Rapid, Sensitive, Quantitative MALDI-TOF MS Assays for Anthrax Lethal Factor and Lethal Toxin, Bacillus-ACT 2009. In Proceedings of the International Bacillus Anthracis, B. Cereus, and B. Thuringiensis Conference, Santa Fe, NM, USA, 30 August-3 September, 2009; American Society for Microbiology: Washington, DC, USA, 2009.
39. Kobiler, D.; Weiss, S.; Levy, H.; Fisher, M.; Mechaly, A.; Pass, A.; Altboum, Z. Protective antigen as a correlative marker for anthrax in animal models. Infect. Immun. 2006, 74, 5871-5876. (Pubitemid 44484574)
40. Mabry, R.; Brasky, K.; Geiger, R.; Carrion, R., Jr.; Hubbard, G.B.; Leppla, S.; Patterson, J.L.; Georgiou, G.; Iverson, B.L. Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin. Vaccine Immunol. 2006, 13, 671-677. (Pubitemid 44032513)
41. Kalb, S.R.; Garcia-Rodriguez, C.; Lou, J.; Baudys, J.; Smith, T.J.; Marks, J.D.; Smith, L.A.; Pirkle, J.L.; Barr, J.R. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS. PLoS One 2010, 5, e12237.
42. Tang, S.; Moayeri, M.; Chen, Z.; Harma, H.; Zhao, J.; Hu, H.; Purcell, R.H.; Leppla, S.H.; Hewlett, I.K. Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles. Clin. Vaccine Immunol. 2009, 16, 408-413.
43. Boyer, A.E.; Quinn, C.P.; Hoffmaster, A.; Gallegos, M.; Saile, E.; Marston, C.; Kozel, T.; Meister, G.; Woolfitt, A.R.; Pirkle, J.L.; Barr, J.R. Kinetics of Toxemia of Inhalation Anthrax. In Proceedings of 6th Annual ASM Biodefense and Emerging Diseases Research Meeting, Baltimore, MD, USA, 24-27 February 2008; American Society for Microbiology: Washington, DC, USA, 2008.
44. Kalb, S.R.; Goodnough, M.C.; Malizio, C.J.; Pirkle, J.L.; Barr, J.R. Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics. Anal. Chem. 2005, 77, 6140-6146. (Pubitemid 41436946)
45. Barr, J.R.; Kalb, S.R.; Moura, H.; Pirkle, J.L. Biological Monitoring of Exposure to Botulinum Neurotoxins. Chem. Health Safety 2008, 15, 14-19.
46. Belmares, J.; Gerding, D.N.; Tillotson, G.; Johnson, S. Measuring the severity of Clostridium difficile infection: Implications for management and drug development. Expert Rev. Anti Infect. Ther. 2008, 6, 897-908.
47. Deshpande, A.; Pant, C.; Jain, A.; Fraser, T.G.; Rolston, D.D. Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence. Curr. Med. Res. Opin. 2008, 24, 329-333. (Pubitemid 351294381)
48. Guris, D.; Strebel, P.M.; Bardenheier, B.; Brennan, M.; Tachdjian, R.; Finch, E.; Wharton, M.; Livengood, J.R. Changing epidemiology of pertussis in the United States: Increasing reported incidence among adolescents and adults, 1990-1996. Clin. Infect. Dis. 1999, 28, 1230-1237. (Pubitemid 29272795)
49. King, A.J.; van Gorkom, T.; Pennings, J.L.; van der Heide, H.G.; He, Q.; Diavatopoulos, D.; Heuvelman, K.; van Gent, M.; van Leeuwen, K.; Mooi, F.R. Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: Identification of genes absent from epidemic strains. BMC Genomics 2008, 9, 311.
50. Godfroid, F.; Denoel, P.; Poolman, J. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence? Expert Rev. Vaccines 2005, 4, 757-778.
51. Kalb, S.R.; Baudys, J.; Egan, C.; Smith, T.J.; Smith, L.A.; Pirkle, J.L.; Barr, J.R. Clostridium baratii Type F Neurotoxin Cleaves Synaptobrevin-2 with Different Substrate Recognition Requirement than Clostridium botulinum Type F Neurotoxin. Appl. Environ. Microbiol. 2011, 77, 1301-1308.